- Home
- SCKT vs HOOK Comparison
SCKT vs HOOK Comparison
Compare SCKT & HOOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCKT
- HOOK
- Stock Information
- Founded
- SCKT 1992
- HOOK 2011
- Country
- SCKT United States
- HOOK United States
- Employees
- SCKT N/A
- HOOK N/A
- Industry
- SCKT Computer Manufacturing
- HOOK Biotechnology: Pharmaceutical Preparations
- Sector
- SCKT Technology
- HOOK Health Care
- Exchange
- SCKT Nasdaq
- HOOK Nasdaq
- Market Cap
- SCKT 9.7M
- HOOK 9.3M
- IPO Year
- SCKT 1995
- HOOK 2019
- Fundamental
- Price
- SCKT $1.12
- HOOK $1.56
- Analyst Decision
- SCKT
- HOOK Buy
- Analyst Count
- SCKT 0
- HOOK 4
- Target Price
- SCKT N/A
- HOOK $10.67
- AVG Volume (30 Days)
- SCKT 10.2K
- HOOK 166.8K
- Earning Date
- SCKT 07-30-2025
- HOOK 06-17-2025
- Dividend Yield
- SCKT N/A
- HOOK N/A
- EPS Growth
- SCKT N/A
- HOOK N/A
- EPS
- SCKT N/A
- HOOK N/A
- Revenue
- SCKT $17,750,643.00
- HOOK $9,351,000.00
- Revenue This Year
- SCKT $8.62
- HOOK N/A
- Revenue Next Year
- SCKT N/A
- HOOK N/A
- P/E Ratio
- SCKT N/A
- HOOK N/A
- Revenue Growth
- SCKT 0.29
- HOOK N/A
- 52 Week Low
- SCKT $0.91
- HOOK $0.72
- 52 Week High
- SCKT $1.72
- HOOK $8.50
- Technical
- Relative Strength Index (RSI)
- SCKT 48.04
- HOOK 56.94
- Support Level
- SCKT $1.06
- HOOK $1.51
- Resistance Level
- SCKT $1.16
- HOOK $1.65
- Average True Range (ATR)
- SCKT 0.06
- HOOK 0.14
- MACD
- SCKT 0.00
- HOOK -0.02
- Stochastic Oscillator
- SCKT 45.79
- HOOK 34.37
About SCKT Socket Mobile Inc.
Socket Mobile Inc is a producer of data capture products. The company's products are integrated into mobile applications used in mobile point of sale (mPOS), commercial services (field workers), asset tracking, manufacturing process and quality control, transportation and logistics (goods tracking and movement), event management (ticketing, entry, access control, and identification), medical and education. The company offers barcode scanning products for both one-dimensional, including imager and laser, and two-dimensional barcode scanning in standard and durable cases. The company's geographical segments are the Americas, Europe, Asia Pacific, and Africa, of which the majority of the revenue is generated from the United States.
About HOOK HOOKIPA Pharma Inc.
HOOKIPA Pharma Inc is a clinical-stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. Its oncology portfolio targets oncoviral cancer antigens and next-generation antigens and includes two primary programs in development: eseba-vec (formerly HB-200) and HB-700. Eseba-vec is in clinical development for the treatment of Human Papillomavirus 16-positive (HPV16+) head and neck cancers. It also develops infectious disease therapies in partnership with other companies. Its Hepatitis B (HBV) program, HB-400, and Human Immunodeficiency Virus (HIV) program, HB-500, are being developed in partnership with Gilead.